Acquiring Company
ClearOne
Acquired Company
Cortigent
Description
Vivani Medical, Inc. has announced a definitive agreement for a merger of its subsidiary Cortigent, Inc. with CLRO Merger Sub, Inc., resulting in Cortigent becoming a wholly owned subsidiary of ClearOne, Inc. The transaction is expected to close in October 2026, pending final regulatory approval. This merger reflects a significant step in ClearOne's strategy to enhance its technological capabilities in the medical sector.
Who to call at ClearOne, and when
When ClearOne changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ClearOne raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ClearOne, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ClearOne. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ClearOne makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cortigent?
Cortigent was acquired by ClearOne, based in Salt Lake City. The deal was reported on October 30, 2026. ClearOne is a global company that designs, develops and sells conferencing, collaboration, and network streaming & signage solutions. ClearOne is publicly traded (CLRO) and operates in Information Technology.
When did ClearOne acquire Cortigent?
ClearOne's acquisition of Cortigent was reported on October 30, 2026. Vivani Medical, Inc. has announced a definitive agreement for a merger of its subsidiary Cortigent, Inc. with CLRO Merger Sub, Inc., resulting in Cortigent becoming a wholly owned subsidiary of ClearOne, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cortigent do?
Cortigent is a subsidiary of Vivani Medical, focusing on the development of innovative medical solutions. The company aims to improve patient outcomes through advanced technology and research. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.